WTS/Pyxis Oncology Inc. EXP07/29/2027

13F holders, Q2 2025 (June 30)
1holders
0new positions
0sold out
$0.00avg. 13F price*

At the end of Q2 2025, 1 institutions reported holding WTS/Pyxis Oncology Inc. EXP07/29/2027 in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was Skaana Management L.P. ($0).

Company
WTS/Pyxis Oncology Inc. EXP07/29/2027
CUSIP
747324119
Latest filing quarter
Q2 2026

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Skaana Management L.P. 0.00% No change 73,130 $0

"% of holder's portfolio" is WTS/PYXIS ONCOLOGY INC EXP07/29/2027's weight in each manager's 13F, not the share of WTS/Pyxis Oncology Inc. EXP07/29/2027 the manager owns.